Last Price
1.55
Today's Change
-0.03 (1.89%)
Day's Change
1.54 - 1.62
Trading Volume
209,429
Market Cap
22 Million
Shares Outstanding
14 Million
Avg Volume
5,694,587
Avg Price (50 Days)
1.66
Avg Price (200 Days)
1.32
PE Ratio
-1.80
EPS
-0.86
Earnings Announcement
11-Nov-2024
Previous Close
1.58
Open
1.56
Day's Range
1.54 - 1.628
Year Range
0.51 - 6.48
Trading Volume
210,122
1 Day Change
-1.90%
5 Day Change
-19.69%
1 Month Change
-27.23%
3 Month Change
103.95%
6 Month Change
63.18%
Ytd Change
30.25%
1 Year Change
-74.34%
3 Year Change
-75.86%
5 Year Change
-75.86%
10 Year Change
-75.86%
Max Change
-75.86%
No result.
Sector: Healthcare - Healthcare
Industry: Drug Manufacturers—General
Description:
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.